Fourth Quarter and Full Year 2024 Summary of Consolidated Results Three Months Ended Year Ended December 31, December 31, ($ in thousands) (unaudited) 2024 2023 2024 2023 Revenue $ 420,070 $ 414,541 $ 1,704,835 $ 1,601,138 Gross Profit (excluding depreciation and amortization) $ 236,605 $ 240,959 $ 989,073 $ 937,926 Net income / (loss) $
HUNTSVILLE, Ala., February 27, 2025–(BUSINESS WIRE)–ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) (“ADTRAN Holdings” or the “Company”) today announced its preliminary unaudited financial results for the fourth quarter and full-year ended December 31, 2024. Adtran Holdings’ Chairman and Chief Executive Officer Tom Stanton stated, “Market conditions continued to improve during the fourth quarter driven
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS) today announced strong financial results for the fourth quarter and full year 2024—including divestiture-adjusted operational revenue growth of 2% for the full year with growth across all segments, new product revenues of $582 million and full year free cash flow that exceeded the Company’s guidance.[2] “2024
MILPITAS, Calif., February 19, 2025–(BUSINESS WIRE)–SolarEdge Technologies, Inc. (Nasdaq: SEDG), a global leader in smart energy technology, today announced its financial results for the fourth quarter ended December 31, 2024 and full year ended December 31, 2024. “There are exciting opportunities ahead for SolarEdge,” said Shuki Nir, CEO of SolarEdge. “We are just getting started
SALT LAKE CITY, February 19, 2025–(BUSINESS WIRE)–PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build today announced financial results for the fourth quarter ended December 31, 2024. “We finished 2024 with an excellent fourth quarter, delivering a third consecutive quarter of strong GMV growth and approximating the
Silo Pharma, Inc. SPC-15 combination treatment shows enhanced efficacy in combating stress-induced psychiatric disorders SARASOTA, FL, Feb. 18, 2025 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a provisional patent application with the
HOUSTON, Feb. 07, 2025 (GLOBE NEWSWIRE) — Prairie Operating Co. (Nasdaq: PROP) (the “Company,” “Prairie,” “we,” “our” or “us”), today announced it has entered into a definitive purchase and sale agreement to acquire (the “Bayswater Acquisition”) certain assets (the “Bayswater Assets”) from Bayswater Exploration and Production and certain of its affiliated entities (collectively “Bayswater”), a
EL SEGUNDO, Calif., Feb. 06, 2025 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading fully integrated precious metals platform, reported results for the fiscal second quarter ended December 31, 2024. “Our second quarter results continue to reflect the strength of our fully-integrated platform to perform profitably even with slower market conditions, elevated
Cargo Therapeutics, Inc. CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a competitive benefit-risk profile for patients. CARGO to implement a workforce reduction of approximately 50%. Phase 1 dose escalation study enrollment for CRG-023 on track to initiate in Q2 2025. SAN CARLOS,
TORONTO, January 22, 2025–(BUSINESS WIRE)–Kontrol Technologies Corp. (CBOE CA:KNR) (OTCQB:KNRLF) (FSE:1K8) (“Kontrol Technologies” or “Kontrol” or “Company”) operates a sustainable buildings platform for customers including REITS, municipalities, property managers and industrial and commercial buildings. The Company continues to review multiple potential acquisition opportunities. The potential acquisitions are subject to customary due diligence and definitive agreements.